Latest News of ELYM
Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m
Private equity firms hold the most power in Eliem Therapeutics with a 53% ownership stake, while institutions and hedge funds also have significant shares. The top 2 shareholders collectively control ...
EVP, R&D AND CSO Valerie Morisset Sells 50,000 Shares of Eliem Therapeutics Inc (ELYM)
Eliem Therapeutics Inc's insider, Valerie Morisset, recently sold 50,000 shares, owning 202,306 now. With a total of 310,650 shares sold in a year, the trend shows more sells than buys....
Insider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ...
Eliem Therapeutics Inc (NASDAQ:ELYM) saw an insider sale by EVP Valerie Morisset, who sold 92,377 shares at $7.04 each, totaling $650,334....